Harmony Biosciences Holdings, Inc. - Common Stock — movimiento trimestral de fondos (NASDAQ:HRMY) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Activos totales 999.2 M1.06 B1.11 B1.21 B1.27 B1.27 B Total de pasivos 340.05 M335.01 M334.93 M373.1 M401.41 M361.48 M Capital total 659.15 M720.52 M773.08 M835.12 M870.22 M910.35 M Total de pasivos y patrimonio neto 999.2 M1.06 B1.11 B1.21 B1.27 B1.27 B Deuda total 163.02 M158.18 M172.09 M168.51 M163.66 M158.81 M Deuda neta 163.02 M158.18 M-411.93 M-524.08 M-631.68 M-482.1 M

Noticias

H.C. Wainwright reitera su recomendación de compra en Harmony Biosciences

ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook

ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised

Harmony Bio Q1 2026: el crecimiento de WAKIX continúa entre inversiones estratégicas

Informe de resultados de Harmony Biosciences Q1 2026: BPA por debajo de lo esperado

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass Estimates

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

HRMY or ARGX: Which Is the Better Value Stock Right Now?

Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet

Should Value Investors Buy CSL Limited (CSLLY) Stock?

H.C. Wainwright reitera calificación de acciones de Harmony Biosciences por perspectivas de litigio de propiedad intelectual